enow.com Web Search

  1. Ad

    related to: myasthenia gravis notes pictures and treatment

Search results

  1. Results from the WOW.Com Content Network
  2. Myasthenia gravis - Wikipedia

    en.wikipedia.org/wiki/Myasthenia_gravis

    Myasthenia gravis affects 50 to 200 people per million. [3] [4] It is newly diagnosed in 3 to 30 people per million each year. [13] Diagnosis has become more common due to increased awareness. [13] Myasthenia gravis most commonly occurs in women under the age of 40 and in men over the age of 60. [1] [5] [14] It is uncommon in children. [1]

  3. Myasthenia gravis is one of the rarest and most concerning ...

    www.aol.com/myasthenia-gravis-one-rarest-most...

    Myasthenia gravis, or MG, is a chronic autoimmune neuromuscular disorder that causes muscle weakness and fatigue. Myasthenia gravis is one of the rarest and most concerning muscular disorders ...

  4. Thymectomy - Wikipedia

    en.wikipedia.org/wiki/Thymectomy

    Thymectomy is a treatment for myasthenia gravis, a neuromuscular disease. [5] For about 60% of people with myasthenia gravis, thymectomy significantly improves their symptoms of muscle weakness. In about 30% of cases, thymectomy results in permanent remission of myasthenia gravis, negating the need for any additional medication.

  5. Transient neonatal myasthenia gravis - Wikipedia

    en.wikipedia.org/wiki/Transient_neonatal...

    Pediatric myasthenia gravis has two other forms which should not be confused with TNMG. Juvenile myasthenia gravis (i.e., JMG) refers to cases of MG that occur in children before the age of 19. It has been diagnosed in children as young as 8 months of age but, unlike TNMG, has not been diagnosed in fetuses (i.e., 9 weeks or older unborn ...

  6. Efgartigimod alfa - Wikipedia

    en.wikipedia.org/wiki/Efgartigimod_alfa

    The study showed that more participants with myasthenia gravis with antibodies responded to treatment during the first cycle of efgartigimod alfa (68%) compared to those who received placebo (30%) on a measure that assesses the impact of myasthenia gravis on daily function. [4]

  7. Repetitive nerve stimulation - Wikipedia

    en.wikipedia.org/wiki/Repetitive_nerve_stimulation

    Repetitive nerve stimulation is a variant of the nerve conduction study where electrical stimulation is delivered to a motor nerve repeatedly several times per second. By observing the change in the muscle electrical response (CMAP) after several stimulations, a physician can assess for the presence of a neuromuscular junction disease, and differentiate between presynaptic and postsynaptic ...

  8. Muscle weakness - Wikipedia

    en.wikipedia.org/wiki/Muscle_weakness

    In some conditions, such as myasthenia gravis, muscle strength is normal when resting, but true weakness occurs after the muscle has been subjected to exercise. This is also true for some cases of chronic fatigue syndrome, where objective post-exertion muscle weakness with delayed recovery time has been measured and is a feature of some of the ...

  9. Pyridostigmine - Wikipedia

    en.wikipedia.org/wiki/Pyridostigmine

    Pyridostigmine is a medication used to treat myasthenia gravis [1] and underactive bladder. [2] It is also used together with atropine to end the effects of neuromuscular blocking medication of the non-depolarizing type. [3] It is also used off-label to treat some forms of Postural orthostatic tachycardia syndrome.

  1. Ad

    related to: myasthenia gravis notes pictures and treatment